Mushrooms, Inc. to Acquire SecurCapital Corp, Plans Strategic Shift Toward Logistics and Supply Chain Growth

Acquisition Marks Full Pivot Into Logistics—Rebranding and New CEO Coming Soon

Mushrooms, Inc. (OTC: MSRM) has announced a definitive Share Exchange Agreement to acquire SecurCapital Corp, marking a major strategic transformation. With the transaction set to close in early March 2026, the company aims to refocus from its legacy biotechnology interests to become a comprehensive supply-chain and logistics solutions provider.

Key Transaction Details: 100% Equity Exchange and Corporate Rebrand Planned

Under the agreement, Mushrooms, Inc. will issue new stock to SecurCapital shareholders in exchange for all of SecurCapital's outstanding equity. Upon closing, SecurCapital will become a wholly owned subsidiary of Mushrooms, Inc. The company intends to rebrand itself as 'SecurCapital Corp,' aligning future investor messaging and public market identity with its new operational direction. The following table outlines the main terms announced:

Strategic Direction: Aggressive Acquisition and Expansion Roadmap

With SecurCapital’s CEO Stephen Russell slated to take over as CEO of the post-merger company, the combined entity will focus exclusively on logistics, supply chain operations, and specialty finance for mid-tier businesses. SecurCapital’s portfolio already generates approximately $10 million in trailing annual revenues, albeit on an unaudited basis. The strategy doesn't stop here: management revealed that new acquisition targets are under negotiation for 2026, with eyes on expanding to new U.S. logistics markets and Southeast Asia’s high-growth air-freight sector.

Leadership Experience Brings Industry Credibility

Stephen Russell, set to lead the newly branded SecurCapital Corp, brings a wealth of global logistics and technology experience. Formerly President and CEO, Asia Pacific at Salesforce (NYSE: CRM), Russell orchestrated Salesforce's early expansion across key Asia-Pacific territories. His logistics background also includes pivotal roles at Circle International and pioneering alliances with leading Silicon Valley tech firms. This leadership signals that Mushrooms, Inc.'s transition year isn’t just about a new name, but a new playbook.

Sharpening Focus: Biotechnology Assets to Be Spun Off

Upon closing, Mushrooms, Inc. also plans to separate its legacy biotechnology assets and activities—specifically the MycoLabX Business. This move is designed to eliminate operational distractions and direct all resources toward scaling SecurCapital’s logistics platform, finance offerings, and upcoming acquisition pipeline.

What This Means for Investors: Real Business, Revenue, and Growth Strategy

For investors, this isn’t just a restructuring—it’s a decisive pivot. The deal transforms Mushrooms, Inc. from a biotech player into a logistics growth platform, with unaudited annual revenues nearing $10 million and a management team with proven industry credentials. While the final outcome hinges on regulatory approvals and the successful integration of businesses, the combination of rebranded leadership, targeted acquisitions, and strategic focus positions the company for tangible growth in a vital sector.

Next Steps: Regulatory Approvals and Integration Risks

The parties expect to complete the transaction within 50 days, pending customary conditions and regulatory approvals. Mushrooms, Inc. will also submit requests to change its corporate name and ticker symbol to FINRA and OTC Markets. Investors should remain aware of integration and execution risks, but the alignment of a public listing, growth roadmap, and new executive leadership could set up Mushrooms, Inc.—soon to be SecurCapital Corp—for a critical next chapter in logistics.

Contact Information:

If you have feedback or concerns about the content, please feel free to reach out to us via email at support@marketchameleon.com.

About the Publisher - Marketchameleon.com:

Marketchameleon is a comprehensive financial research and analysis website specializing in stock and options markets. We leverage extensive data, models, and analytics to provide valuable insights into these markets. Our primary goal is to assist traders in identifying potential market developments and assessing potential risks and rewards.

NOTE: Stock and option trading involves risk that may not be suitable for all investors. Examples contained within this report are simulated and may have limitations. Average returns and occurrences are calculated from snapshots of market mid-point prices and were not actually executed, so they do not reflect actual trades, fees, or execution costs. This report is for informational purposes only, and is not intended to be a recommendation to buy or sell any security. Neither Market Chameleon nor any other party makes warranties regarding results from its usage. Past performance does not guarantee future results. Please consult a financial advisor before executing any trades. You can read more about option risks and characteristics at theocc.com.

The information is provided for informational purposes only and should not be construed as investment advice. All stock price information is provided and transmitted as received from independent third-party data sources. The Information should only be used as a starting point for doing additional independent research in order to allow you to form your own opinion regarding investments and trading strategies. The Company does not guarantee the accuracy, completeness or timeliness of the Information.

Disclosure: This article was generated with the assistance of AI